[1]
“Rational Use of Immunoglobulin in Adult Patients with Secondary Hypogammaglobulinemia in the Setting of Hematologic Malignancy: A Canadian Perspective”, Can Hematol Today, vol. 4, no. 3, pp. 37–54, Dec. 2025, doi: 10.58931/cht.2025.4380.